Company: BLUWU
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012302
Chunk: 195

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-05-23
Form: S-1/A
Chunk 195
---
Officers, Directors and Director Nominees

Our officers, directors and director nominees are as follows:

| Name                |     | Age |     | Position                                                 |
| Joseph Hernandez    |     |  52 |     | Chief                                                    
 Executive Officer and Chairman of the Board of Directors |
| Martha              
 F. Ross             |     |  62 |     | Chief                                                    
 Financial Officer                                        |
| Timothy             
 N. Coulson          |     |  56 |     | Director                                                 
 nominee                                                  |
| Trevor              
 L. Hawkins          |     |  56 |     | Director                                                 
 nominee                                                  |
| Ish S. Dugal        |     |  42 |     | Director Nominee                                         |
| Laurent D. Hermouet |     |  55 |     | Director Nominee                                         |

Joseph Hernandez, our Chairman and Chief Executive Officer since inception, is an entrepreneurial leader with over 25 years of experience in the healthcare field. He is the Founder of Blue Water Venture Partners, LLC, an investment firm, where he is also the Senior Managing Partner. Along with Blue Water Venture Partners, LLC, Mr. Hernandez is the Chairman and Founder of several other biotechnology companies including, Perseus Therapeutics, Inc., spun out of Duke University and focused on developing novel therapies for preventing hair loss in chemotherapy-treated cancer patients and for cosmetic use; Temple Street Biotech, Inc., focused on advancing Alzheimer’s disease treatments; Eternity Biotech, spun out of Yale University and committed to developing advancements life extension; and Energia Power Systems, Inc., spun out of Stanford University, a novel battery company. Mr. Hernandez has a background in company creation, early stage technology development, as well as private and public market financing. Mr. Hernandez brings leadership to the team, backed by a strong educational foundation in biology, medicine, molecular genetics, microbiology, epidemiology, marketing, and finance. Over the course of his career, he has founded or led fourteen entrepreneurial companies in cutting edge areas of healthcare and pharmaceuticals. After years of building his career at Merck & Co. (NYSE: MRK) from December 1998 to January 2001, and Digene Corp., a medical diagnostics firm (acquired by Qiagen NV (NYSE: QGEN)) from 2005 to 2009, Mr. Hernandez founded and became the President and Chief Executive Officer of Innovative Biosensors, Inc., a biotech company, from 2004 to 2009. Later, Mr